Although the impact of GLP-1RAs on CD outcomes is not well defined, some preclinical data suggest that GLP-1RAs have anti-inflammatory and gut barrier-protective effects
10.2337/diabetes.48.1.86 71
Same taste, same use in everything (cereal, shakes, coffee, cooking)
With the implicit validity of these data given the expected weight regain seen after therapy cessation, there is some credence to the idea that this is a genuine reflection of nondurability of weight loss with GLP-1 receptor agonist therapy
As part of getting organised and being fully equipped to forge ahead with our lobbying activities, I conducted a review of the questions asked so far in the UK Parliament about B12 deficiency and Pernicious Anaemia
Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act